RICHMOND, Va. (AP) — Virginia Commonwealth University is studying genetic markets that may predict chronic depression.
The Richmond school says it has received a $3 million grant from National Institute of Mental Health for the five-year study.
Officials say the findings may lead to a more tailored and improved treatment of depression.
The study will be done by VCU’s Center for Biomarker Research and Personalized Medicine in collaboration with the VU University in Amsterdam.
The center has been in operation since 2006. Its mission is to develop and apply methods to identify and use biomarkers to improve understanding of disease and tailor medication use in patients to enhance efficacy.